Items 101 to 110 of 168 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Atazanavir | 198904-31-3 | sc-207305 | 5 mg | $286.00 | 7 | |
Atazanavir is a potent protease inhibitor that selectively targets the HIV-1 protease enzyme, crucial for viral replication. Its unique structure allows for specific interactions with the enzyme's active site, leading to the formation of stable enzyme-inhibitor complexes. This binding alters the conformational dynamics of the protease, effectively blocking the cleavage of viral polyproteins. The compound's distinct pharmacokinetic profile, including its metabolism via the liver, contributes to its prolonged action in biological systems. | ||||||
1-Methyl-5-aminomethylimidazole | 486414-86-2 | sc-258810 sc-258810A | 250 mg 1 g | $192.00 $544.00 | ||
1-Methyl-5-aminomethylimidazole exhibits unique properties as an antiinfective agent through its ability to interact with specific biological targets. Its imidazole ring facilitates hydrogen bonding and coordination with metal ions, enhancing its reactivity. The compound's electron-rich nitrogen atoms can participate in nucleophilic attacks, influencing various biochemical pathways. Additionally, its solubility characteristics allow for effective diffusion across cellular membranes, impacting its bioavailability and interaction kinetics. | ||||||
Desethylene Ciprofloxacin, Hydrochloride | 528851-31-2 | sc-207532 | 5 mg | $342.00 | ||
Desethylene Ciprofloxacin, Hydrochloride demonstrates distinctive behavior as an antiinfective through its structural features that promote strong interactions with bacterial DNA gyrase and topoisomerase IV. The presence of fluorine atoms enhances its lipophilicity, facilitating membrane penetration. Its ability to form stable complexes with target enzymes alters their activity, disrupting bacterial replication. Furthermore, the compound's pH-dependent solubility influences its distribution and efficacy in various environments. | ||||||
N-Vinyl-e-caprolactam | 2235-00-9 | sc-269900 | 100 g | $49.00 | ||
N-Vinyl-e-caprolactam exhibits unique properties as an antiinfective through its ability to undergo radical polymerization, forming hydrophilic networks that can interact with biological membranes. Its cyclic structure allows for specific hydrogen bonding and dipole interactions, enhancing its affinity for target sites. Additionally, the compound's reactivity with nucleophiles can lead to the formation of adducts, potentially modulating biological pathways and influencing cellular responses. | ||||||
2-Bromo-1-benzothiophene | 5394-13-8 | sc-259548 sc-259548A | 250 mg 1 g | $75.00 $214.00 | ||
2-Bromo-1-benzothiophene demonstrates intriguing behavior as an antiinfective due to its ability to engage in electrophilic aromatic substitution, allowing it to form stable complexes with nucleophilic sites in biological systems. The presence of the bromine atom enhances its reactivity, facilitating interactions with various biomolecules. Its unique thiophene ring structure contributes to π-π stacking interactions, potentially influencing cellular signaling pathways and modulating immune responses. | ||||||
Econazole | 27220-47-9 | sc-279013 | 5 g | $240.00 | ||
Econazole exhibits notable characteristics as an antiinfective through its ability to disrupt fungal cell membrane integrity. Its imidazole ring facilitates the inhibition of ergosterol synthesis, a critical component of fungal membranes, by interacting with cytochrome P450 enzymes. This interaction alters membrane fluidity and permeability, leading to cell lysis. Additionally, its lipophilic nature enhances membrane penetration, promoting effective bioavailability in target organisms. | ||||||
Cefepime | 88040-23-7 | sc-278815 | 50 mg | $720.00 | ||
Cefepime, a fourth-generation cephalosporin, exhibits remarkable stability against hydrolysis by various beta-lactamases, enhancing its efficacy against resistant bacteria. Its unique structure allows for efficient penetration through the outer membrane of Gram-negative bacteria, facilitating access to target sites. The compound's affinity for penicillin-binding proteins leads to potent inhibition of cell wall synthesis, disrupting bacterial growth through a well-coordinated mechanism of action. | ||||||
Ciprofloxacin lactate | 97867-33-9 | sc-278849 | 100 mg | $300.00 | ||
Ciprofloxacin lactate, a fluoroquinolone derivative, demonstrates a distinctive mechanism of action by inhibiting bacterial DNA gyrase and topoisomerase IV, crucial enzymes for DNA replication and repair. Its lipophilic nature enhances membrane permeability, allowing for rapid intracellular accumulation. The compound exhibits a unique pH-dependent solubility profile, influencing its distribution and bioavailability. Additionally, its broad-spectrum activity stems from effective binding to bacterial targets, disrupting essential cellular processes. | ||||||
Enrofloxacin hcl | 112732-17-9 | sc-279015 | 1 g | $1227.00 | ||
Enrofloxacin HCl, a synthetic fluoroquinolone, exhibits potent antibacterial properties through its ability to chelate metal ions, which can enhance its interaction with bacterial enzymes. This compound demonstrates a unique affinity for the bacterial cell membrane, facilitating its penetration and subsequent action. Its stability in acidic environments allows for prolonged activity, while its rapid absorption kinetics contribute to effective therapeutic outcomes. The compound's structural features enable selective targeting of bacterial topoisomerases, disrupting critical DNA processes. | ||||||
Ziagen | 136470-78-5 | sc-338739 sc-338739A | 1 g 5 g | $130.00 $400.00 | 1 | |
Ziagen, an antiretroviral agent, operates through unique interactions with viral enzymes, particularly reverse transcriptase. Its structure allows for effective incorporation into viral DNA, leading to chain termination. The compound exhibits a distinct affinity for specific nucleoside binding sites, enhancing its efficacy. Additionally, its solubility profile supports optimal bioavailability, while its metabolic pathways involve phosphorylation, resulting in active triphosphate forms that inhibit viral replication. |